Pregnancy: Risk-benefit must be considered since jaundice and prolonged extra pyramidal effects have been reported in the neonates of mothers who receive some fluphenazine near terms. It is not recommended for use during pregnancy.
Breast-feeding: Risk-benefit must be considered since small amounts of some phenothiazine have been found in breast milk, possibly causing drowsiness and an increased risk of dystonias and tardive dyskinesia in the baby. Most phenothiazines increase prolactin secretion in the mother.